Do we still need studies on the value of the TIVAD for cancer patients?
Department of Surgical Sciences, Organ Transplantation, and Advanced Technologies, University of Catania, Cannizzaro Hospital, Via Messina 829, 95126, Catania, Italy, idicarlo@unict.it.
Isidoro
I
Di Carlo
Adriana
A
Toro
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002406:Catheterization, Peripheral; D002408:Catheters, Indwelling; D005260:Female; D006801:Humans; D017060:Patient Satisfaction; D062666:Vascular Access Devices
D000970:Antineoplastic Agents